PRKAB1 and lymphoma: It is particularly instructive to compare this model with our own more recently published model of T-ALL [167], where AMPK-α1 had been specifically knocked out in T-cell progenitors prior to lymphomas starting to occur, in which basal AMPK was clearly protecting against development of lymphomas, and in which activation of AMPK using phenformin provided further protection.